Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Piccini, K. Stromberg, Kevin Jackson, V. Laager, G. Duray, Mikhael El-Chami, Christopher Ellis, J. Hummel, D. Jones, Robert Kowal, C. Narasimhan, R. Omar, P. Ritter, Paul Roberts, K. Soejima, Shu Zhang, D. Reynolds (2017)
Long-term outcomes in leadless Micra transcatheter pacemakers with elevated thresholds at implantation: Results from the Micra Transcatheter Pacing System Global Clinical Trial.Heart rhythm, 14 5
T. Mela, Jagmeet Singh (2015)
Leadless pacemakers: leading us into the future?European heart journal, 36 37
BfArM Customer Information. http (2016)
08980_16_Kundeninfo_de
M. Vamos, J. Erath, A. Benz, Z. Bari, G. Duray, S. Hohnloser (2017)
Incidence of Cardiac Perforation With Conventional and With Leadless Pacemaker Systems: A Systematic Review and Meta‐AnalysisJournal of Cardiovascular Electrophysiology, 28
Extraction of the Micra transcatheter pacemaker System
(2014)
Extraction of the Micra transcatheter pacemaker System. Presented at HRS
(2017)
leading us into the future? Eur Heart J
M. Bongiorni, L. Segreti, A. Cori, M. Bonner, M. Eggen, Pamela Omdahl (2015)
Retrieval of a transcatheter pacemaker in sheep after a mid-term implantation timeHeartRhythm Case Reports, 2
Vivek Reddy, D. Exner, Daniel Cantillon, Rahul Doshi, T. Bunch, G. Tomassoni, P. Friedman, N. Estes, J. Ip, I. Niazi, K. Plunkitt, R. Banker, J. Porterfield, J. Ip, Srinivas Dukkipati (2015)
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.The New England journal of medicine, 373 12
(BfArM Customer Information. http://www.bfarm.de/SharedDocs/Kundeninfos/DE/01/2016/08980_16_Kundeninfo_de.pdf?__blob=publicationFile&v=2. Accessed 28 Oct 2016.)
BfArM Customer Information. http://www.bfarm.de/SharedDocs/Kundeninfos/DE/01/2016/08980_16_Kundeninfo_de.pdf?__blob=publicationFile&v=2. Accessed 28 Oct 2016.BfArM Customer Information. http://www.bfarm.de/SharedDocs/Kundeninfos/DE/01/2016/08980_16_Kundeninfo_de.pdf?__blob=publicationFile&v=2. Accessed 28 Oct 2016., BfArM Customer Information. http://www.bfarm.de/SharedDocs/Kundeninfos/DE/01/2016/08980_16_Kundeninfo_de.pdf?__blob=publicationFile&v=2. Accessed 28 Oct 2016.
St. Jude Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices Panel Meeting Date (2016)
February 18
V. Reddy, R. Knops, J. Sperzel, M. Miller, J. Petrů, J. Simon, L. Šedivá, J. Groot, F. Tjong, P. Jacobson, Alan Ostrosff, Srinivas Dukkipati, J. Koruth, A. Wilde, J. Kautzner, P. Neužil (2014)
Permanent Leadless Cardiac Pacing: Results of the LEADLESS TrialCirculation, 129
et al. Extraction of the Micra transcatheter pacemaker System. Presented at HRS Bonner MD (2014)
Bonner MD, et al. Extraction of the Micra transcatheter pacemaker System. Presented at HRS 2014. Poster Session IV.
G. Duray, P. Ritter, Mikhael El-Chami, C. Narasimhan, R. Omar, J. Tolosana, Shu Zhang, K. Soejima, C. Steinwender, Leonardo Rapallini, A. Cicic, D. Fagan, Shufeng Liu, D. Reynolds (2017)
Long-term performance of a transcatheter pacing system: 12-Month results from the Micra Transcatheter Pacing Study.Heart rhythm, 14 5
D. Reynolds, G. Duray, R. Omar, K. Soejima, P. Neužil, Shu Zhang, C. Narasimhan, C. Steinwender, J. Brugada, M. Lloyd, P. Roberts, V. Sagi, J. Hummel, M. Bongiorni, R. Knops, Christopher Ellis, C. Gornick, Matthew Bernabei, V. Laager, K. Stromberg, Eric Williams, J. Hudnall, P. Ritter (2016)
A Leadless Intracardiac Transcatheter Pacing System.The New England journal of medicine, 374 6
(St. Jude Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices Panel Meeting Date: February 18, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM485095.pdf. Accessed 20 January 2016.)
St. Jude Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices Panel Meeting Date: February 18, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM485095.pdf. Accessed 20 January 2016.St. Jude Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices Panel Meeting Date: February 18, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM485095.pdf. Accessed 20 January 2016., St. Jude Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices Panel Meeting Date: February 18, 2016. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM485095.pdf. Accessed 20 January 2016.
Vivek Reddy, Marc Miller, R. Knops, P. Neužil, P. Defaye, W. Jung, Rahul Doshi, M. Castellani, A. Strickberger, R. Mead, Harish Doppalapudi, D. Lakkireddy, M. Bennett, J. Sperzel (2016)
Retrieval of the Leadless Cardiac Pacemaker: A Multicenter ExperienceCirculation: Arrhythmia and Electrophysiology, 9
(2016)
Medical Nanostim Leadless Pacemaker Panel Pack for Circulatory System Devices
Pamela Omdahl, M. Eggen, M. Bonner, P. Iaizzo, K. Wika (2016)
Right Ventricular Anatomy Can Accommodate Multiple Micra Transcatheter PacemakersPacing and Clinical Electrophysiology, 39
R. Kirkfeldt, J. Johansen, E. Nøhr, O. Jørgensen, J. Nielsen (2013)
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in DenmarkEuropean Heart Journal, 35
E. Udo, N. Zuithoff, N. Hemel, C. Cock, T. Hendriks, P. Doevendans, K. Moons (2012)
Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study.Heart rhythm, 9 5
Abstract Leadless pacing is now an established alternative to conventional pacing with subcutaneous pocket and transvenous lead for patients with class I or II single-chamber pacing indication. Available 12-month follow-up data shows a 48% fewer major complication rate in patients with Micra™ compared to a historical control group in a nonrandomized study [1]. There is one system with Food and Drug Administration (FDA) approval and two with the Communauté Européenne (CE) mark. The OPS code for the implantation is 8–83d.3 and the procedure has recently been rated as a “new Examination and Treatment Method (NUB)” in the German DRG system, meaning adequate reimbursement is negotiable with health insurance providers. The systems offer similar generator longevity and programming possibilities as conventional pacemaker systems, including rate response, remote monitoring, and MRI safety. The biggest downsides to date are limitations to single-chamber stimulation, lack of long-time data, and concerns of handling of the system at the end of its life span. However, implant procedure complication rates and procedure times do not exceed conventional pacemaker operations, and proper training and patient selection is provided.
Cardiology and Therapy – Springer Journals
Published: Dec 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.